Technical Analysis for SBBP - Strongbridge Biopharma plc

Grade Last Price % Change Price Change
grade F 3.03 -0.33% -0.01
SBBP closed down 0.33 percent on Friday, May 17, 2019, on 61 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical SBBP trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -0.33%
Narrow Range Bar Range Contraction -0.33%

Older signals for SBBP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
Strongbridge Biopharma plc, a biopharmaceutical company, through its subsidiary, Cortendo AB (publ), develops, acquires, and commercializes product candidates that target rare diseases. The company's lead product candidate, COR-003 (levoketoconazole), is a cortisol inhibitor that is in the Phase 3 trial for the treatment of endogenous Cushing's syndrome. It also has two product candidates, COR-004 and COR-005 in Phase 2 clinical development to treat acromegaly. In addition, it is developing BP-2001, a pre-clinical product candidate for the treatment of diabetes. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania.
Chemistry Biopharmaceutical Organ Systems Chemical Compounds Diabetes Rare Diseases Chloroarenes Treatment Of Diabetes Acromegaly Cushing's Syndrome Adrenal Gland Disorders Cortisol Endogenous Cushing's Syndrome Piperazines
Is SBBP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 10 The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma's Weak Breast Cancer Drug Sales
May 9 Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Academy of Neurology Annual Meeting
May 8 The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split
May 3 The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen
May 2 Edited Transcript of SBBP earnings conference call or presentation 1-May-19 12:30pm GMT
May 2 The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data
May 2 Strongbridge Biopharma (SBBP) Q1 2019 Earnings Call Transcript
May 1 46 Stocks Moving In Wednesday's Mid-Day Session
May 1 Strongbridge Biopharma (SBBP) Reports Q1 Loss, Lags Revenue Estimates
May 1 FTR, NUS, PBI and ENPH among midday movers
See more SBBP news...
Indicators
Indicator Value
52 Week High 7.765
52 Week Low 3.0
Average Volume 233,244
200-Day Moving Average 4.8094
50-Day Moving Average 4.5236
20-Day Moving Average 3.8065
10-Day Moving Average 3.217
Average True Range 0.2134
ADX 47.47
+DI 7.1515
-DI 38.63
Chandelier Exit (Long, 3 ATRs ) 4.3498
Chandelier Exit (Short, 3 ATRs ) 3.6402
Upper Bollinger Band 5.2133
Lower Bollinger Band 2.3997
Percent B (%b) 0.22
BandWidth 73.915671
MACD Line -0.4541
MACD Signal Line -0.4017
MACD Histogram -0.0524
Fundamentals Value
Market Cap 107.06 Million
Num Shares 35.3 Million
EPS -2.93
Price-to-Earnings (P/E) Ratio -1.03
Price-to-Sales 139.82
Price-to-Book 21.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.17
Resistance 3 (R3) 3.17 3.13 3.14
Resistance 2 (R2) 3.13 3.10 3.13 3.13
Resistance 1 (R1) 3.08 3.07 3.08 3.08 3.13
Pivot Point 3.04 3.04 3.04 3.04 3.04
Support 1 (S1) 2.99 3.01 2.99 2.99 2.93
Support 2 (S2) 2.95 2.98 2.95 2.93
Support 3 (S3) 2.90 2.95 2.92
Support 4 (S4) 2.90